abstract |
A subject-matter of the present invention is pharmaceutical compositions comprising, in combination, (S)-(-)-N-[4-(4-acetamido-4-phenylpiperidin-1yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide or one of its pharmaceutically acceptable salts with a selective serotonin reuptake inhibitor or with a serotonin/norepinephrine reuptake inhibitor. |